ArticleClinical and translational science2025

Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis.

Patrick BrossardPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.